SenesTech, Inc. (NASDAQ:SNES – Get Free Report) shares passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $2.84 and traded as low as $2.02. SenesTech shares last traded at $2.10, with a volume of 18,752 shares traded.
Wall Street Analyst Weigh In
A number of brokerages have commented on SNES. StockNews.com began coverage on shares of SenesTech in a research note on Monday, March 17th. They set a “sell” rating for the company. HC Wainwright boosted their target price on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.
Get Our Latest Analysis on SNES
SenesTech Stock Up 1.9 %
SenesTech (NASDAQ:SNES – Get Free Report) last issued its quarterly earnings data on Wednesday, March 12th. The company reported ($1.22) earnings per share for the quarter, beating the consensus estimate of ($1.50) by $0.28. SenesTech had a negative return on equity of 150.33% and a negative net margin of 403.51%. The business had revenue of $0.50 million for the quarter, compared to analysts’ expectations of $0.71 million. On average, research analysts expect that SenesTech, Inc. will post -10.22 EPS for the current year.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- Breakout Stocks: What They Are and How to Identify Them
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- The Significance of Brokerage Rankings in Stock Selection
- Top 3 Beverage Stocks Pouring Out Profits
- Where Do I Find 52-Week Highs and Lows?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.